Featured
Plausible Mechanism Pathway Comments
Plausible Mechanism Pathway Comments
PRESS RELEASE: Haystack Project Files Petition for Rulemaking to Establish Context-Based Evidence Framework for Rare Diseases
PRESS RELEASE: Haystack Project Files Petition for Rulemaking to Establish Context-Based Evidence Framework for Rare Diseases
Haystack Project Petitions FDA To Adopt Context-Driven Evidence Approach For Rare Therapies
Haystack Project Petitions FDA To Adopt Context-Driven Evidence Approach For Rare Therapies
Haystack Project’s Petition for Rulemaking
Haystack Project’s Petition for Rulemaking
RDEP Open Letter to FDA
RDEP Open Letter to FDA
Experts: New FDA Rare Disease Program Offers Nothing Novel
Experts: New FDA Rare Disease Program Offers Nothing Novel
Newborn Screening Coalition Letter
Newborn Screening Coalition Letter
US FDA’s Makary Floats Vague ‘Plausible Mechanism’ Approval Pathway For Rare Diseases
US FDA’s Makary Floats Vague ‘Plausible Mechanism’ Approval Pathway For Rare Diseases
Makary Pitches Rare Disease Approvals Based On ‘Plausible Mechanism’
Makary Pitches Rare Disease Approvals Based On ‘Plausible Mechanism’
Pink Sheet: Woodcock Warns of ‘Excessive Worship Of The RCT,’ Pushes New Drug Approval Pathway
Pink Sheet: Woodcock Warns of ‘Excessive Worship Of The RCT,’ Pushes New Drug Approval Pathway